Ciprofloxacin in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): A Population Pharmacokinetic Study
Extracorporeal membrane oxygenation (ECMO) is utilized to temporarily sustain respiratory and/or cardiac function in critically ill patients. Ciprofloxacin is used to treat nosocomial infections, but data describing the effect of ECMO on its pharmacokinetics is lacking. Therefore, a prospective, obs...
Saved in:
Main Authors: | Dzenefa Alihodzic (Author), Sebastian G. Wicha (Author), Otto R. Frey (Author), Christina König (Author), Michael Baehr (Author), Dominik Jarczak (Author), Stefan Kluge (Author), Claudia Langebrake (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of Inaccurate Documentation of Sampling and Infusion Time in Model-Informed Precision Dosing
by: Dzenefa Alihodzic, et al.
Published: (2020) -
Impact of Extracorporeal Membrane Oxygenation (ECMO) on Serum Concentrations of Cefepime
by: Christopher J. Destache, et al.
Published: (2024) -
No Sequestration of Commonly Used Anti-Infectives in the Extracorporeal Membrane Oxygenation (ECMO) Circuit-An Ex Vivo Study
by: Hendrik Booke, et al.
Published: (2024) -
Hemodynamics guided care during extracorporeal membrane oxygenation (ECMO): a case report
by: Mohamed Al Kanjo, et al.
Published: (2024) -
Surgical Expertise in Neonatal Extracorporeal Membrane Oxygenation (ECMO): A Single Center Experience
by: Francesco Macchini, et al.
Published: (2019)